Results 181 to 190 of about 12,043,843 (293)

Impact of Denosumab Adherence on Renal Function and Mortality Rates in Type 2 Diabetes Patients With Osteoporosis

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporosis and fractures, and denosumab, a non‐kidney‐excreted antiresorptive medication, represents a viable alternative to bisphosphonates for osteoporosis treatment in patients with T2DM. This study aimed to investigate the association among denosumab adherence, renal
Yu‐Chuan Chang   +7 more
wiley   +1 more source

Gender-Related Differences in the Levels of Ambulatory BP and Intensity of Antihypertensive Treatment in Patients Undergoing Peritoneal Dialysis. [PDF]

open access: yesLife (Basel), 2023
Kontogiorgos I   +9 more
europepmc   +1 more source

Short-Term Risk of Serious Fall Injuries in Older Adults Initiating and Intensifying Treatment With Antihypertensive Medication [PDF]

open access: bronze, 2016
Daichi Shimbo   +7 more
openalex   +1 more source

Perioperative Antihypertensive Treatment in Patients With Spontaneous Intracerebral Hemorrhage

open access: yesStroke, 2017
Jun Zheng   +9 more
semanticscholar   +1 more source

Effects of Changes in Metabolic Syndrome Status on Cognitive Function: A 10‐Year Study in a Middle‐Aged Population

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The long‐term cumulative impact of metabolic syndrome (MS) on cognitive decline remains uncertain. This study investigated how changes in MS status over 10 years relate to cognition and whether sex modifies this relationship. A total of 766 participants (mean baseline age: 54 years) from the Kaohsiung Atherosclerosis Longitudinal Study were ...
Kelly Lim   +6 more
wiley   +1 more source

Evaluating alternative methods of comparing antihypertensive treatment intensity. [PDF]

open access: yesAm J Manag Care, 2022
Aubert CE   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy